Latest Ileus Stories
A disposal, plastic listening device that attaches to the abdomen may help doctors definitively determine which post-operative patients should be fed and which should not
Tranzyme Pharma today announced positive Phase IIb results for its first-in-class, highly potent and selective ghrelin agonist, TZP-101, for the management of postoperative ileus (POI).
Chewing gum following colon surgery to remove all or part of the colon may enhance recovery of intestinal function, British researchers say. Sanjay Purkayastha and colleagues at St.
Adolor Corporation (NASDAQ:ADLR) announced today that over 500 hospitals have now enrolled in the Entereg Access Support & Education (E.A.S.E.(TM)) Program. The Company estimates that these hospitals perform approximately 20% of the annual bowel resection procedures in the United States. The E.A.S.E.
Tranzyme Pharma, a leading biopharmaceutical company developing novel mechanism-based therapeutics for the treatment of gastrointestinal (GI) and metabolic disorders, announced today that the Company has received Notices of Allowance from the U.S.
Tranzyme Pharma announces the successful results from a "Thorough QT/QTc" study of the company's lead product TZP-101, an intravenous gastrointestinal prokinetic agent currently in two Phase IIb trials for the treatment of postoperative ileus (POI) and severe gastroparesis.
By Hiromura, Katsuhiko Furuhashi, Madoka; Minami, Kojiro; Miyazaki, Ken; Et al Abstract Septic shock during pregnancy is very rare but has high mortality.
CHICAGO (Reuters) - Chewing gum after intestinal surgery can help reactivate paralyzed bowels and get patients out of the hospital sooner, a study said on Monday.